Precision BioSciences Stock

Precision BioSciences is a biotechnology company dedicated to improving life.

About Precision BioSciences Stock

Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS. Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.

Funding History

March 2006	$0
May 2015	$25.6M
June 2018	$110M
March 2019	$39.5M

Management

Co-Founder and Chief Executive Officer

Matthew Kane

Director of Human Resources

Molly Lukes

Chief Development Officer, Executive Vice President

David Thomson

CEO, Elo

Fayaz Khazi

Co-Founder and Chief Technical Officer

Jeff Smith

Co-Founder and Chief Scientific Officer

Derek Jantz

Press

How To Spot A Synthetic Biology Unicorn

Forbes - Sep, 27 2019

Uber and Other IPOs Set for an Index Bounce

Wall Streets Journal - Jun, 14 2019

Reshaping human health and changing lives through gene editing

TechCrunch - May, 21 2016

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Request Access

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2023 EquityZen Inc. All rights reserved.